INVESTOR RELATIONS
press release – price-sensitive
02/10/2025
ARTERRA BIOSCIENCE ANNOUNCES THE SIGNING OF THE ADDENDUM TO THE VITALAB SHAREHOLDERS’ AGREEMENT29/09/2025
THE BOARD OF DIRECTORS HAS APPROVED THE HALF-YEARLY REPORT AS OF 30 JUNE 202501/08/2025
ARTERRA BIOSCIENCE S.P.A. HAS SOLD ITS ENTIRE STAKE IN THE SHARE CAPITAL OF LONGEVITY BIOSCIENCE S.R.L. EQUAL TO € 43,999.1731/07/2025
ARTERRA BIOSCIENCE S.P.A. HAS SOLD ITS ENTIRE STAKE IN THE SHARE CAPITAL OF LONGEVITY BIOSCIENCE S.R.L.18/07/2025
TURNOVER AT JUNE 30, 2025, APPROXIMATELY 2.6 MILLION EUROS12/06/2025
ARTERRA BIOSCIENCE S.P.A. PARTICIPATES IN THE “FINANCIAL GALÀ” EVENT ORGANIZED BY INTEGRAE SIM ON 19 JUNE 202519/05/2025
FINANCING AND GRANTING OF INCENTIVES FOR THE “SmartLAB 2.0” PROJECT WORTH APPROXIMATELY €3 MILLION06/05/2025
TURNOVER AS OF MARCH 31, 2025 EQUAL TO APPROXIMATELY 1.3 MILLION EUROS